MedPath

The effect of sexual counseling on quality of sexual life in women surviving breast cancer

Not Applicable
Conditions
Breast cancer and sexual dysfunction and quality of sexual life.
Registration Number
IRCT20210926052601N1
Lead Sponsor
Oroumia University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
90
Inclusion Criteria

Women of childbearing age (18-49 years)
Married and living together with his wife, are not on the verge of divorce
Attendance of spouse at least two weeks a month
Do not be pregnant or breastfeeding
If the diagnosis of breast cancer has been confirmed in her, filing a case in the hospital is required to provide written confirmation of the disease by an oncologist.
Do not have an underlying or chronic illness other than breast cancer, especially severe mental illness
Experience one of the mastectomy methods
Do not take drug and alcohol
Stage I, II, IIIa cancer
Last at least 6 months and at most 5 years after completing radiation therapy and chemotherapy
Do not receive special treatment to treat your sexual function problems, such as psychotherapy or attend training classes
The person's spouse, according to him, has a dysfunction
Access to her for at least the next four months
Smartphone and Internet access

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The effect of sexual counseling on improving sexual function and quality of sexual life in breast cancer survivors. Timepoint: Evaluation of the improvement of sexual function and sexual quality in women surviving breast cancer before the intervention and then immediately and 4 weeks after the intervention. Method of measurement: General Health Questionnaire (GHQ 28), Questionnaire related to demographic characteristics and disease status, - Women's Sexual Quality of Life Questionnaire (F-SQOL, Sexual Function Scale for Adapted Women for Breast Cancer) BC-FSFI.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath